Pulse Biosciences, Inc.PLSENASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR-41.4%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-41.4%/yr
Quarterly compound
Percentile
P82
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.38% |
| Q3 2025 | -0.45% |
| Q2 2025 | -12.36% |
| Q1 2025 | 10.94% |
| Q4 2024 | -48.38% |
| Q3 2024 | -16.45% |
| Q2 2024 | -10.47% |
| Q1 2024 | 15.30% |
| Q4 2023 | -11.38% |
| Q3 2023 | -10.02% |
| Q2 2023 | -6.95% |
| Q1 2023 | -9.34% |
| Q4 2022 | 51.48% |
| Q3 2022 | -28.62% |
| Q2 2022 | 18.87% |
| Q1 2022 | -12.09% |
| Q4 2021 | -7.97% |
| Q3 2021 | 3.60% |
| Q2 2021 | 20.08% |
| Q1 2021 | -34.67% |
| Q4 2020 | -6.59% |
| Q3 2020 | -13.66% |
| Q2 2020 | 4.99% |
| Q1 2020 | 14.21% |
| Q4 2019 | -16.43% |
| Q3 2019 | -2.70% |
| Q2 2019 | -11.90% |
| Q1 2019 | -14.90% |
| Q4 2018 | 16.72% |
| Q3 2018 | -16.98% |
| Q2 2018 | -6.60% |
| Q1 2018 | 1.21% |
| Q4 2017 | -17.36% |
| Q3 2017 | -20.96% |
| Q2 2017 | -92.18% |
| Q1 2017 | -13.86% |
| Q4 2016 | -1.61% |
| Q3 2016 | -23.75% |
| Q2 2016 | -34.26% |
| Q1 2016 | -9.71% |